TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3790404

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) administered under fasting conditions
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) administered after a standardised breakfast
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) administered under fasting conditions in the evening (adults only)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intravenous theophylline as a reference
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sustained release theophylline (SRT) in children with food
Number of subjects: 16
Study: 29525770

Group type: EXPERIMENTAL
Intervention: Combined classroom curriculum and parental intervention (STAMPP)
Number of subjects: 10233

Group type: COMPARATOR
Intervention: Alcohol education as normal (EAN)
Number of subjects: 10233
Study: 26676203

Group type: EXPERIMENTAL
Intervention: Immediate implants placed in fresh sockets associated with chronic periapical disease (test group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy fresh sockets (control group)
Number of subjects: 60
Study: 24512981

Group type: EXPERIMENTAL
Intervention: Trabectedin 1.5mg/m2 24‐h intravenous infusion every 3 weeks (Arm A)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Doxorubicin 75 mg/m2 i.v., q3wk or doxorubicin 60 mg/m2 plus ifosfamide (6‐9 g/m2) i.v. q3wk (Arm B)
Number of subjects: 121
Study: 23265034

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.25%
Number of subjects: 30
Study: 20656163

Group type: EXPERIMENTAL
Intervention: Intracameral epinephrine (0.2 mL, 1:5000 solution)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (no epinephrine)
Number of subjects: 149
Study: 18635256

Group type: EXPERIMENTAL
Intervention: Methotrexate plus etanercept 50 mg/week
Number of subjects: 542

Group type: COMPARATOR
Intervention: Methotrexate alone (titrated from 7.5 mg to 20 mg/week)
Number of subjects: 542
Study: 15766304

Group type: EXPERIMENTAL
Intervention: Levetiracetam (500 to 1000 mg titrated to 2000 mg/day, maximum 3000 mg/day)
Number of subjects: 34
Study: 12186343

Group type: EXPERIMENTAL
Intervention: Initial preparation (IP) including scaling and root planing followed by apically repositioned flap surgery
Number of subjects: 18

Group type: COMPARATOR
Intervention: Initial preparation (IP) only
Number of subjects: 18
Study: 10568044

Group type: EXPERIMENTAL
Intervention: Tardyferon (1 tablet per day for two months starting on the 4th day after delivery)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tardyferon Fol (1 tablet per day for two months starting on the 4th day after delivery)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No medication (Control group)
Number of subjects: 60
Study: 8923571

Group type: EXPERIMENTAL
Intervention: brofaromine or fluvoxamine
Number of subjects: 44
Study: 2009366

Group type: EXPERIMENTAL
Intervention: 1 mg/kg per day cyclosporine A (CyA) from day -1 to day +20 after bone marrow transplant (BMT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: 5 mg/kg per day cyclosporine A (CyA) from day -1 to day +20 after bone marrow transplant (BMT)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 1 mg/kg per day cyclosporine A (CyA)
Number of subjects: 81

Group type: COMPARATOR
Intervention: 5 mg/kg per day cyclosporine A (CyA)
Number of subjects: 81
Study: 7171417

Group type: EXPERIMENTAL
Intervention: Pre-treatment with tubocurarine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Suxamethonium administration
Number of subjects: 0
Study: 31348298

Group type: EXPERIMENTAL
Intervention: Auricular electroacupuncture combined with body acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study: 30477832

Group type: EXPERIMENTAL
Intervention: Tualang Honey (20g/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Honey Cocktail (20g/day)
Number of subjects: 100
Study: 26836285

Group type: EXPERIMENTAL
Intervention: Diffuse pain pattern
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Anterior-medial pain pattern
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Medial-posterior pain pattern
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Overall pain patterns
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: WOMAC and ICOAP scores
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Neuropathic-like symptoms
Number of subjects: 164
Study: 24593664

Group type: EXPERIMENTAL
Intervention: Topical petroleum jelly (2 g/kg, twice daily until 34 weeks of gestation)
Number of subjects: 74

Group type: COMPARATOR
Intervention: No topical petroleum jelly treatment (Control)
Number of subjects: 74
Study: 22523271

Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: BI strain
Number of subjects: 999

Group type: COMPARATOR
Intervention: Non-BI strains
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: BI infection
Number of subjects: 999
Study: 20226040

Group type: EXPERIMENTAL
Intervention: recombinant FSH (Gonal-F)
Number of subjects: 0

Group type: COMPARATOR
Intervention: human menopausal gonadotropin (hMG; Menopur)
Number of subjects: 0
Study: 17366280

Group type: EXPERIMENTAL
Intervention: EEG neurofeedback (NF) training to increase peak alpha frequency (PAF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15629989

Group type: EXPERIMENTAL
Intervention: Bedside ultrasound of the bladder performed before catheterization
Number of subjects: 248

Group type: COMPARATOR
Intervention: Observation phase (no ultrasound)
Number of subjects: 248
Study: 12552349

Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 30
Study: 10475357

Group type: EXPERIMENTAL
Intervention: 50 mg Pygeum africanum extract twice daily
Number of subjects: 209

Group type: COMPARATOR
Intervention: 100 mg Pygeum africanum extract once daily
Number of subjects: 209
Study: 8984863

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation applied to the median nerve
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation applied to the ulnar nerve
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 3
Study: 1683182

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 97

Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 97
Study: 31117088

Group type: EXPERIMENTAL
Intervention: Enarodustat 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enarodustat 4 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enarodustat 6 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enarodustat (any dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28540514

Group type: EXPERIMENTAL
Intervention: Myringotomy and ventilation tube insertion
Number of subjects: 43

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 43
Study: 25012183

Group type: EXPERIMENTAL
Intervention: Higher Intensity Intermittent Exercise (HIIE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Lower Intensity Intermittent Exercise (LIIE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 48
Study: 23617248

Group type: COMPARATOR
Intervention: Sodium hyaluronate (SH) 0.15% 1 drop × 5 times/day for 90 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH) 0.15% + amino acids mixture 1 drop × 5 times/day for 90 days
Number of subjects: 40
Study: 20877394

Group type: EXPERIMENTAL
Intervention: Ground hazelnuts
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sliced hazelnuts
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Whole hazelnuts
Number of subjects: 48
Study: 19158801

Group type: EXPERIMENTAL
Intervention: 5% albumin (10 ml kg(‐1))
Number of subjects: 33

Group type: COMPARATOR
Intervention: Normal saline (NS) (10 ml kg(‐1))
Number of subjects: 33
Study: 17680182

Group type: EXPERIMENTAL
Intervention: Continuous epidural ropivacaine at 6 mg x h(‐1) (group R‐6)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous epidural ropivacaine at 18 mg x h(‐1) (group R‐18)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Continuous epidural ropivacaine at 12 mg x h(‐1)
Number of subjects: 60
Study: 10711584

Group type: EXPERIMENTAL
Intervention: Lower levels of stress and depressive symptoms in women who quit early in pregnancy.
Number of subjects: 819

Group type: COMPARATOR
Intervention: Adjusting for level of addiction and other demographic factors.
Number of subjects: 819

Group type: EXPERIMENTAL
Intervention: Lower levels of stress and depressive symptoms.
Number of subjects: 819

Group type: EXPERIMENTAL
Intervention: Targeted intensive cessation interventions.
Number of subjects: 819

Group type: EXPERIMENTAL
Intervention: Interventions that reduce stress and depression.
Number of subjects: 819
Study: 8968181

Group type: EXPERIMENTAL
Intervention: Pall BB2215 heat and moisture exchanger (HME) hydrophobic filter
Number of subjects: 23

Group type: COMPARATOR
Intervention: Fisher Paykell hot water system
Number of subjects: 23

Group type: COMPARATOR
Intervention: Dar Hygrobac 35254111 HME hygroscopic filter
Number of subjects: 23
Study: 1637767

Group type: EXPERIMENTAL
Intervention: Ayre's spatula
Number of subjects: 856

Group type: COMPARATOR
Intervention: Aylesbury
Number of subjects: 856

Group type: COMPARATOR
Intervention: Rocket
Number of subjects: 856

Group type: COMPARATOR
Intervention: Multispatula
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Cytobrush
Number of subjects: 856
Study: 6143340

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30651080

Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT) programme
Number of subjects: 554

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 554
Study: 29392749

Group type: EXPERIMENTAL
Intervention: Mobile application-based treatment for urinary incontinence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study: 26358951

Group type: EXPERIMENTAL
Intervention: Group A: two sessions of real MC rTMS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Group B: one session of real rTMS and one session of sham rTMS
Number of subjects: 24
Study: 24374602

Group type: EXPERIMENTAL
Intervention: Alternative positioning device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional positioning methods
Number of subjects: 100
Study: 22746019

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% after spinal anesthesia (0.2%S group)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% after epidural anesthesia (0.2%E group)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1% after epidural anesthesia (0.1%E group)
Number of subjects: 81
Study: 20443719

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol gel (1 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oral estradiol valerate (2 mg) with or without medroxyprogesterone acetate (5 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 17355218

Group type: EXPERIMENTAL
Intervention: Cisplatin/pemetrexed combination chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy options
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newest biologically targeted therapies
Number of subjects: 0
Study: 16287371

Group type: EXPERIMENTAL
Intervention: Superslow resistance training (SST) using 50% of 1RM
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional resistance training (TRT) using 80% of 1RM
Number of subjects: 16
Study: 12119821

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (XyliFresh 100%, Hershey Food Corporation, U.S.A.) chewed three times a day for three weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study: 14528568

Group type: EXPERIMENTAL
Intervention: Low-frequency exercise training program
Number of subjects: 114

Group type: COMPARATOR
Intervention: High-frequency exercise training program
Number of subjects: 114
Study: 8527615

Group type: EXPERIMENTAL
Intervention: 10 mg famotidine
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study: 2260727

Group type: EXPERIMENTAL
Intervention: Borage oil (4.5 ml/day for 4 weeks)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fish oil (4.5 ml/day for 4 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (safflower oil, 4.5 ml/day for 4 weeks)
Number of subjects: 29
Study: 31654345

Group type: EXPERIMENTAL
Intervention: OAGB-BSGP (staplerless one-anastomosis gastric bypass with band-separated gastric pouch)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard OAGB (stapled one-anastomosis gastric bypass)
Number of subjects: 80
Study: 27292093

Group type: EXPERIMENTAL
Intervention: Biological treatments for psoriasis (specifics on dosage and duration not provided)
Number of subjects: 0
Study: 24870567

Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training (IMT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-intensity inspiratory muscle training (IMT)
Number of subjects: 28
Study: 23386553

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural therapy (CBT)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Skills training for symptom management (SM)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 78
Study: 21663610

Group type: EXPERIMENTAL
Intervention: Vitality Exercise Programme (VEP) combined with three visits to a Personal Vitality Coach (PVC)
Number of subjects: 730
Study: 20039417

Group type: EXPERIMENTAL
Intervention: Terguride
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 17175404

Group type: EXPERIMENTAL
Intervention: Precontemplation stage of change
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Action stage of change
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Both stages of change
Number of subjects: 301

Group type: COMPARATOR
Intervention: Previous alcohol use, age, and education
Number of subjects: 301

Group type: COMPARATOR
Intervention: Temptation to drink alcohol
Number of subjects: 301
Study: 15897799

Group type: EXPERIMENTAL
Intervention: Baseline plasma interleukin (IL)-6 and soluble tumor necrosis factor receptor (sTNFR) 1 concentrations
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: APACHE II and MOD scores, age
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Baseline total protein C, IL-8, IL-10, TNF-alpha, and procalcitonin concentrations
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Change in plasma cytokine concentrations from baseline over the initial 4 days
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Combination of selected baseline proinflammatory cytokine concentrations and APACHE II score
Number of subjects: 124
Study: 12201833

Group type: EXPERIMENTAL
Intervention: Zinc supplementation regimens
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Nutritional rehabilitation
Number of subjects: 141
Study: 9615816

Group type: EXPERIMENTAL
Intervention: Narrow excision of primary tumor with 1 cm-wide margins in 305 patients
Number of subjects: 612

Group type: COMPARATOR
Intervention: Wide excision with margins within 3 cm in 307 patients
Number of subjects: 612
Study: 7642861

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 2540786

Group type: EXPERIMENTAL
Intervention: Oral administration of lisinopril (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous administration of lisinopril (5 mg)
Number of subjects: 12
Study: 345994

Group type: EXPERIMENTAL
Intervention: Lynestrenol (10 mg per day from the 10th to the 24th day of the cycle)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 33
Study: 31289060

Group type: EXPERIMENTAL
Intervention: Tailored approach in which probands decide which relatives to inform themselves and which to have informed by the genetic counsellor.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Tailored approach.
Number of subjects: 85
Study: 27095035

Group type: EXPERIMENTAL
Intervention: Health promotion intervention program taught by trained teachers
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 464
Study: 25121567

Group type: EXPERIMENTAL
Intervention: Multi‐Intervention Programme (MIP), 48 sessions, 16 weeks duration
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Multi‐Intervention Programme (MIP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 61
Study: 23768094

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (specific details on dosage and duration not available)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (specific details not available)
Number of subjects: 0
Study: 21745357

Group type: EXPERIMENTAL
Intervention: Joint protection delivered by an occupational therapist (OT)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Hand exercises delivered by an occupational therapist (OT)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Joint protection and hand exercises combined
Number of subjects: 252

Group type: COMPARATOR
Intervention: Leaflet and advice
Number of subjects: 252
Study: 19929112

Group type: EXPERIMENTAL
Intervention: Repeated Monte Carlo simulations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pooling of data
Number of subjects: 0
Study: 16876040

Group type: EXPERIMENTAL
Intervention: 3% sodium hypochlorite (NaOCl) applied for 30 seconds before pulpotomy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional calcium hydroxide pulpotomy (Control)
Number of subjects: 18
Study: 14678133

Group type: EXPERIMENTAL
Intervention: Atrial prevention pacing ON
Number of subjects: 298

Group type: COMPARATOR
Intervention: Atrial prevention pacing OFF
Number of subjects: 298
Study: 11214014

Group type: EXPERIMENTAL
Intervention: Allopurinol (1 g)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 9381383

Group type: EXPERIMENTAL
Intervention: Lovastatin (40-60-80 mg daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Lovastatin with plasmapheresis
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no hypolipidemic therapy)
Number of subjects: 42
Study: 8095854

Group type: EXPERIMENTAL
Intervention: GM‐CSF‐primed PBP and GM‐CSF (Group 2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: GM‐CSF alone (Group 1)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PBP and GM‐CSF (Group 3)
Number of subjects: 18
Study: 3094207

Group type: EXPERIMENTAL
Intervention: Short-term cyclosporine (CsA)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional azathioprine and low-dose prednisolone (AP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control biopsies (day 0)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Biopsies several years after transplantation (AP therapy)
Number of subjects: 83
Study: 30343314

Group type: EXPERIMENTAL
Intervention: AR-301 (human monoclonal antibody)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (buffer)
Number of subjects: 48
Study: 26117081

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) training workshop for alcohol SBI
Number of subjects: 20

Group type: COMPARATOR
Intervention: No MI training (control group)
Number of subjects: 20
Study: 23334785

Group type: EXPERIMENTAL
Intervention: 810-nm continuous wave low-level laser therapy (LLLT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (no laser irradiation)
Number of subjects: 37
Study: 22183484

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol combination
Number of subjects: 10
Study: 20207746

Group type: EXPERIMENTAL
Intervention: Programmable vibrating patient notifiers (PN ON)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group (PN OFF)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Both groups (PN ON and PN OFF)
Number of subjects: 356
Study: 18562774

Group type: EXPERIMENTAL
Intervention: Rest with carbohydrate (CHO) supplementation (RCHO)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Resistance exercise with carbohydrate (CHO) supplementation (ECHO)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Rest with placebo (RPL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Resistance exercise with placebo (EPL)
Number of subjects: 9
Study: 16365224

Group type: EXPERIMENTAL
Intervention: Dornase alfa (2.5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hypotonic saline solution (5 mL)
Number of subjects: 24
Study: 11722829

Group type: EXPERIMENTAL
Intervention: Various smoking cessation interventions based on the Theory of Self‐Efficacy, Transtheoretical Model of Readiness for Change, and Theory of Addictions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 9604976

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS), 200 microg twice a day
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray, 200 microg twice a day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 34
Study: 7699845

Group type: EXPERIMENTAL
Intervention: SY5555 administered at daily doses between 3.4-10 mg/kg, t.i.d., for 3-14 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: SY5555
Number of subjects: 45
Study: 2773845

Group type: EXPERIMENTAL
Intervention: Iron-folic acid supplements for 60 days
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Varying dosages of elemental iron
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Iron supplementation for 4 and 8 months
Number of subjects: 319
Study: 411668

Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 400 mg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 300 mg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 200 mg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Spironolactone (Aldactone) 100 mg/day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45